Back to Search
Start Over
DNA demethylating therapy reverts mesenchymal stromal cells derived from high risk myelodysplastic patients to a normal phenotype
- Source :
- British journal of haematology. 177(5)
- Publication Year :
- 2016
- Subjects :
- 0301 basic medicine
Azacitidine
Antineoplastic Agents
Immunophenotyping
03 medical and health sciences
chemistry.chemical_compound
0302 clinical medicine
Bone Marrow
medicine
Humans
business.industry
Myelodysplastic syndromes
Mesenchymal stem cell
Mesenchymal Stem Cells
Hematology
DNA Methylation
medicine.disease
Phenotype
030104 developmental biology
medicine.anatomical_structure
chemistry
Cellular Microenvironment
030220 oncology & carcinogenesis
Myelodysplastic Syndromes
DNA methylation
Cancer research
Bone marrow
business
DNA
Biomarkers
medicine.drug
Subjects
Details
- ISSN :
- 13652141
- Volume :
- 177
- Issue :
- 5
- Database :
- OpenAIRE
- Journal :
- British journal of haematology
- Accession number :
- edsair.doi.dedup.....5e59020ddff2226ddc5eb80992fbf109